Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji.

Slides:

Advertisements

Similar presentations

Pulmonary Involvement in Inflammatory Bowel Disease

Advertisements

Squamous Cell Carcinoma of the Pericardium Found During Coronary Bypass Surgery of Possible Cutaneous Origin Alan P. Kypson, MD, Curtis A. Anderson,

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Collision Tumor of Esophagus: Report of Three Cases

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Lung Cancer Staging: A Case for a New T Definition

Christopher B. Horn, MD, Nikhil R. Patel, BA, Jennifer A

Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer Kyohei Masai, MD, Hiroyuki Sakurai,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Primary Chordoma of the Lung

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Cavity Wall Thickness in Solitary Cavitary Lung Adenocarcinomas Is a Prognostic Indicator Yukio Watanabe, MD, Masahiko Kusumoto, MD, Akihiko Yoshida,

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Surgical Repair of a Chronic Traumatic Sternal Fracture

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Use of Amiodarone After Major Lung Resection

Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer Takayuki Fukui, MD, Toshiki Okasaka, MD, Koji Kawaguchi,

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma Hajime Watanabe, MD, Haruhiro Saito, MD, Tomoyuki.

Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Radiologic Classification of Small Adenocarcinoma of the Lung: Radiologic-Pathologic Correlation and Its Prognostic Impact Kenji Suzuki, MD, Masahiko.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Splenic Rupture Caused by Giant Paraesophageal Hernia

Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator Akiko Miyagi Maeshima, MD, Naobumi Tochigi,

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Editorial Board, January 2010

Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,

C-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas Koji Tsuta, MD, PhD, Yoshiki Kozu, MD, PhD, Takahiro.

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan Kenji Suzuki, MD, Hisao Asamura,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy Samina Park, MD, In Kyu Park, MD, PhD, Young Tae.

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Recurrent Intrapulmonary Solitary Fibrous Tumor With Malignant Transformation Takuya Inoue, MD, Yuki Owada, MD, Yuzuru Watanabe, MD, Satoshi Muto, MD,

Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Primary Yolk Sac Tumor of the Lung

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

The Impact of New Technology on Cardiothoracic Surgical Practice

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

Presentation transcript:

Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, Koji Tsuta, MD, Masahiko Kusumoto, MD, Akihiko Yoshida, MD, Kenji Suzuki, MD, Hisao Asamura, MD, Hitoshi Tsuda, MD The Annals of Thoracic Surgery Volume 97, Issue 1, Pages 245-251 (January 2014) DOI: 10.1016/j.athoracsur.2013.09.018 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Adenocarcinoma component with lepidic predominant and squamous cell component are completely separated from one another. (Hematoxylin and eosin; ×10.) The Annals of Thoracic Surgery 2014 97, 245-251DOI: (10.1016/j.athoracsur.2013.09.018) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 High-resolution computed tomographic image showing inflammatory changes surrounding the tumor in centrally located adenosquamous carcinoma. The Annals of Thoracic Surgery 2014 97, 245-251DOI: (10.1016/j.athoracsur.2013.09.018) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 (A) Overall survival curves for adenosquamous carcinoma cases. (B) Recurrence-free survival curves for adenosquamous carcinoma cases. The Annals of Thoracic Surgery 2014 97, 245-251DOI: (10.1016/j.athoracsur.2013.09.018) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Overall survival (OS) analysis. (A) OS curves for patients with never smoker and former or current smoker status (p = 0.05). (B) OS curves for patients with tumor size >5 cm and ≦ 5cm (p < 0.001). (C) OS curves for patients with stage I or II and III or IV (p < 0.001). (D) OS curves for patients with positive and negative CT findings of inflammatory changes surrounding the tumor (p < 0.001). The Annals of Thoracic Surgery 2014 97, 245-251DOI: (10.1016/j.athoracsur.2013.09.018) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions